This site contains promotional content intended for UK Healthcare Professionals and other relevant decision makers | Not a HCP? Visit our  Public Site.

Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below. 

Cardiovascular
Cardiovascular
Womens Health
Women's Health
two kidneys
Nephrology
Oncology
Oncology
Ophthalmology
Ophthalmology
Respiratory
Respiratory
Bayer for ProfessionalsYour Resource Portal
Ophthalmology Podcasts

The Macular Minute Episode 10

with Bhavin Maru

The Macular Minute Banner

Practicalities of Using EYLEA® (aflibercept) 8 mg in Routine Clinical Practice

In this

4-minute
episode, we are joined by
Bhavin Maru
, a Lead Nurse in Ophthalmology at Imperial College Healthcare NHS Trust, to discuss
some of the practicalities associated with using EYLEA 8 mg solution for injection (in a vial) in routine clinical practice in the UK
.

 

This promotional podcast series has been organised and funded by Bayer and is for UK healthcare professionals only.

 

This podcast was created prior to the approval of the EYLEA 8 mg pre-filled syringe. Please contact your local Bayer representative to arrange training for use of the EYLEA 8 mg pre-filled syringe.

View instructions for use for administering EYLEA 8 mg from a vial

here
.

 

Prescribing information for EYLEA® (aflibercept) 8 mg

can be found here
.

Prescribing information for EYLEA® (aflibercept) 2 mg

can be found here
.

Bhavin Maru

Bhavin Maru is an accomplished and highly skilled nurse leader in the field of ophthalmology. With a career spanning over two decades, Bhavin has dedicated himself to the care and advancement of eye health and actively contributes to international and national teaching initiatives. He collaborates with various hospitals, including private institutions, and partners with pharmaceutical companies to advance ophthalmic care worldwide.

 

Speaker Disclosures

Speaker fees and travel support from Bayer

References

  1. EYLEA® 40 mg/mL Summary of Product Characteristics.
  2. EYLEA® 114.3 mg/mL Summary of Product Characteristics.
EYLEA® (aflibercept) 8 mg
Discover data and resources about EYLEA 8 mg
PP-EYL-GB-2911, July 2025
The Macular Minute: Podcast Series
Your source for quick expert insights in medical retina
PP-EYL-GB-2538, January 2025
EYLEA® (aflibercept) 2 mg
Discover data and resources about EYLEA 2 mg
PP-EYL-GB-2793, March 2025

PP-EYL-GB-2550 | January 2025